Project 4213

Advanced Oxidation of Pharmaceuticals and Personal Care Products

$203,419
Completed
Principal Investigator
Desmond Lawler
Project Manager
Hsiao-wen Chen
Contractor
University of Texas at Austin
Advanced Treatment
Endocrine Disrupting Compounds and Pharmaceuticals & Personal Care Products (EDCs & PPCPs)
Treatment

Abstract

This project determined and characterized the impact of background organic matrices on the efficiency of ozone-based advanced oxidation processes for removal of pharmaceutically active compounds (PhACs). The project developed a strategy that employs bioassays for assessing the ability of treatment processes to remove PhACs. It also evaluated the potential of the bioassay residual testing strategy to predict the impact of background organic matter on treatment performance. Published in 2016.